Cannabis Strategic Ventures (OTC: NUGS) is providing a way
for athletes to improve their health and relieve joint and muscle pain through
Fitamins, a proprietary health and wellness formula comprised of 25 mg of
hemp-derived, THC-free CBD in addition to other joint-supporting vitamins. A
recent article discussing the company reads, “NUGS acquired the Fitamins CBD brand
in August 2018 (http://ibn.fm/3PcG2).
Products under the brand consist of vitamin and hemp-derived CBD formulations,
which will be distributed through Fitamins’ network of 600+ wholesalers
catering to the Asian-American market. The agreement between the companies
calls for Fitamins to produce a proprietary CBD product as part of NUGS’ brand
portfolio, initially targeting United States distribution networks and
eventually expanding into Asian markets that have legalized CBD products.”
To view the full article, visit http://ibn.fm/X7wAS
About Cannabis Strategic Ventures Inc.
Cannabis Strategic Ventures is a Los Angeles-based firm that
incubates, develops and partners with category leaders within the cannabis
sector. The firm’s NUGS brand experience provides mentorship and a range of
essential services to emerging and existing cannabis consumer brands. The
company recently completed a name and symbol change from Cascade Energy Inc.
Cannabis Strategic Ventures is publicly traded on the U.S. Over-the-Counter
Market with the stock symbol NUGS. For more information, visit the company’s
website at www.CannabisStrategic.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
